Compare Unichem Lab with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB VENUS REMEDIES UNICHEM LAB/
VENUS REMEDIES
 
P/E (TTM) x 60.5 -1.1 - View Chart
P/BV x 0.7 0.1 850.4% View Chart
Dividend Yield % 2.1 0.0 -  

Financials

 UNICHEM LAB   VENUS REMEDIES
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
VENUS REMEDIES
Mar-18
UNICHEM LAB/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs292126 231.9%   
Low Rs18261 297.9%   
Sales per share (Unadj.) Rs167.7301.8 55.6%  
Earnings per share (Unadj.) Rs-3.6-24.9 14.6%  
Cash flow per share (Unadj.) Rs5.92.5 233.5%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs372.3293.3 126.9%  
Shares outstanding (eoy) m70.3812.34 570.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.40.3 456.2%   
Avg P/E ratio x-65.3-3.8 1,736.3%  
P/CF ratio (eoy) x39.936.7 108.6%  
Price / Book Value ratio x0.60.3 199.7%  
Dividend payout %-110.20-   
Avg Mkt Cap Rs m16,6801,154 1,445.7%   
No. of employees `0002.60.9 281.3%   
Total wages/salary Rs m2,393393 608.8%   
Avg. sales/employee Rs Th4,535.24,026.1 112.6%   
Avg. wages/employee Rs Th919.8425.0 216.4%   
Avg. net profit/employee Rs Th-98.2-331.8 29.6%   
INCOME DATA
Net Sales Rs m11,8013,724 316.9%  
Other income Rs m98423 4,373.8%   
Total revenues Rs m12,7853,747 341.2%   
Gross profit Rs m-835395 -211.5%  
Depreciation Rs m674338 199.1%   
Interest Rs m75354 21.2%   
Profit before tax Rs m-600-275 217.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-34332 -1,086.9%   
Profit after tax Rs m-256-307 83.3%  
Gross profit margin %-7.110.6 -66.7%  
Effective tax rate %57.3-11.5 -499.0%   
Net profit margin %-2.2-8.2 26.3%  
BALANCE SHEET DATA
Current assets Rs m20,3842,638 772.8%   
Current liabilities Rs m5,0292,305 218.2%   
Net working cap to sales %130.18.9 1,455.1%  
Current ratio x4.11.1 354.1%  
Inventory Days Days105135 77.4%  
Debtors Days Days13546 291.1%  
Net fixed assets Rs m9,0234,871 185.3%   
Share capital Rs m141123 114.1%   
"Free" reserves Rs m26,0583,496 745.4%   
Net worth Rs m26,1993,619 723.9%   
Long term debt Rs m01,374 0.0%   
Total assets Rs m31,4967,509 419.5%  
Interest coverage x-7.00.2 -3,128.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.40.5 75.5%   
Return on assets %-0.60.6 -90.7%  
Return on equity %-1.0-8.5 11.5%  
Return on capital %-2.01.6 -126.4%  
Exports to sales %69.40-   
Imports to sales %013.9 0.0%   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNA517 0.0%   
Fx inflow Rs m8,1880-   
Fx outflow Rs m596517 115.4%   
Net fx Rs m7,592-517 -1,469.9%   
CASH FLOW
From Operations Rs m-3,278514 -637.2%  
From Investments Rs m-2,860-123 2,323.4%  
From Financial Activity Rs m-24-387 6.3%  
Net Cashflow Rs m-4,6904 -111,671.4%  

Share Holding

Indian Promoters % 50.1 32.9 152.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.2 8,388.9%  
FIIs % 3.0 0.6 517.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 66.4 47.7%  
Shareholders   20,176 20,121 100.3%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   GLENMARK PHARMA  FULFORD INDIA  WYETH LTD  DIVIS LABORATORIES  ALEMBIC LTD  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, VENUS REMEDIES has posted a net profit of Rs 104 m (down 11.1% YoY). Sales on the other hand came in at Rs 864 m (down 7.3% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

VENUS REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 2301.8% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, VENUS REMEDIES has posted a net profit of Rs 119 m (down 2301.8% YoY). Sales on the other hand came in at Rs 691 m (down 25.8% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Sep 13, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - ALEMBIC LTD COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS